Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
This study will address the cognitive dysfunction associated with MS. It will track these changes and show that early intervention with Avonex is effective in slowing MS and its effect on patients. Safety data will also be collected during this study.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
CIS (according to indication) or early Relapsing Remitting Multiple Sclerosis
